Curtis Scribner
Institution Name:
Total Awards:
1
Award Value:
$5,516,253
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Aspera Biomedicines, Inc | Rebecsinib, an RNA Splicing and Base Editing Inhibitor to Target Cancer Stem Cells in Refractory Myeloid Malignancies | $5,516,253 |
| Total: $5,516,253.00 |